It has been hypothesised that inflammatory molecules (often raised in active RA), such as tumour necrosis factor (TNF), interleukin-6 (IL-6) and C-reactive protein (CRP), may contribute to fatigue symptoms. This evidence concerns the gene IL6 and rheumatoid arthritis.